EIF4E and central nervous system cancer: Ribavirin shows promising effects against cancer via suppressing eIF4E phosphorylation and activation and leading to decreased mRNA export and protein synthesis in pharyngeal, ovarian, breast cancer, acute lymphoblastic leukemia (ALL), osteosarcoma, and glioma [187,188,189,190,191,192,193,194].